Back to search results
NCT05368064

Cleidocranial Dysplasia (CCD): From Genotype to Phenotype and Considerations for Care

Enrolling by Invitation
Not specifiedAll AgesObservational
Johns Hopkins University
~300 participants
Updated 2025-10-22 on ClinicalTrials.gov
What's tested:observational

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Presence of RUNX2 mutation
Measured over 3 years
+1 more outcome measured

Conditions

Cleidocranial Dysostosis

Explore related trials

Cleidocranial Dysplasia

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Ilana Ickow, DMD, MS · PRINCIPAL_INVESTIGATOR · Johns Hopkins University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient has molecular or clinical diagnosis of CCD
Caregiver or parent of patient with CCD.

Exclusion

Patient does not have CCD
Patient over 18 but cannot consent for themselves
Not fluent in English.

What this trial measures

  • Presence of RUNX2 mutation3 years

    identify the RUNX2 mutation in each participant

  • Phenotypic description of each patient with CCD3 years

    Physical exam, dental exam, medical history collection